Science
Leica Biosystems Unveils its Aperio GT 450 DX Digital Pathology Sca...
- Artificial Intelligence
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Science
- Vendor products
PRESS RELEASE - 11 August, 2020 - Leica Biosystems, a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly...
Glasgow, Scotland, 30th April 2020: A UK-based biotechnology firm has announced the discovery of two separate novel treatments for Covid-19 patients before they are put on ventilators. They are now urgently seeking funding of £4m to...
Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...
OncoLens Offering Virtual Tumor Board Platform at No Cost
- Advocacy
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Conferences
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- General Healthcare News
- Health Technology Collaboration
- Informatics
- Laboratory Informatics
- Medical Research
- Pathology News
- Science
- Storage
- TeleHealth
- Tissue banking
- Vendor products
- Web/Tech
- Whole slide
In response to COVID-19, we are offering the OncoLens Virtual Tumor Board module at no cost, through the end of May, 2020. The module enables cancer care teams to meet completely virtually, in real time, to discuss treatment options for their...
These twelve artificial intelligence innovations are expected to start impacting clinical care by the end of the decade. By Jennifer Bresnick of HeatlhITAnalytics.com There’s no question that artificial intelligence is moving...
Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...
































